Molecular Pathology Laboratory Network (MPLN) Tennessee July 15, 2015 – Announced today that they have received accreditation for ISO 15189. MPLN is one of eight (8) laboratories in the US to receive this accreditation and one of four (4) laboratories designated as “available for commercial use”. Accreditation was received for Clinical Testing that includes the following specialties: Infectious Disease, Clinical Cytogenetics, Flow Cytometry and Pathology (Histopathology and Molecular Pathology).
ISO 15189:2012 specifies requirements for quality and competence in medical laboratories performing moderate or high complexity testing as defined in 42CFR493. Assessment by the American Association for Laboratory Accreditation (A2LA) ISO 15189 Accreditation Program is provided by ILAC MRA signatory in the US. A2LA has designed this program not to replace but to complement the Clinical Laboratory Improvement Amendments (CLIA).
Commenting is turned off for this post.
Commenting is not available in this channel entry.